Trail

Summary : Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced the companies have submitted an application to the U.S. Food…

Summary : AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic…

Summary : Results from a phase 3 trial evaluating AstraZeneca and Sanofi’s jointly developed treatment nirsevimab – the first investigational long-acting antibody, designed to protect…

Summary : AstraZeneca and Sanofi secured accelerated authorization for respiratory syncytial virus (RSV) antibody nirsevimab from the European Medicines Agency. Nirsevimab was…

Summary : A new study shows why certain NK cells are activated when encountering a cell infected with SARS-CoV-2. The infected cells…

Synopsis: For at least six months after COVID-19 vaccination, antibodies produced by immune cells become steadily more formidable and more precisely targeted…

Summary : A nationwide study from the U.S. Centers for Disease Control and Prevention (CDC) is the first to show that immunity…

It’s uncertain if we will ever determine the origins of COVID-19. The current top theories split about evenly between a lab leak from…

Summary : Critically ill COVID-19 patients on a mechanical ventilator or extracorporeal membrane oxygenation (ECMO) lived more often when randomized to receive…

Summary : AstraZeneca (AZ) has reported preliminary data from a trial it conducted on its COVID-19 booster shot, Vaxzevria. The results from…